1. A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification. (December 2017) Authors: Angevin, Eric; Spitaleri, Gianluca; Rodon, Jordi; Dotti, Katia; Isambert, Nicolas; Salvagni, Stefania; Moreno, Victor; Assadourian, Sylvie; Gomez, Corinne; Harnois, Marzia; Hollebecque, Antoine; Azaro, Analia; Hervieu, Alice; Rihawi, Karim; De Marinis, Filippo Journal: European journal of cancer Issue: Volume 87(2017) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characteristics of the Metastatic Breast Cancer Population with PIK3CA Mutation in the Randomized Phase II Study SAFIR02 Breast (UCBG-0105/1304). (November 2017) Authors: Lefeuvre-Plesse, Claudia; Lusque, Amélie; Bieche, Ivan; Lacroix, Ludovic; Arnedos, Monica; Campone, Mario; Dalenc, Florence; Gonçalves, Anthony; Le Du, Fanny; Jacquet, Alexandra; Bonnefoi, Hervé; Attignon, Valéry; Sablin, Marie-Paule; Soubeyran, Isabelle; Jézéquel, Pascal; Ferrero, Jean-Marc; Isa... Journal: Breast Issue: Volume 36(2017) Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exosomes in cancer theranostic: Diamonds in the rough. Issue 2 (4th March 2017) Authors: Cordonnier, Marine; Chanteloup, Gaëtan; Isambert, Nicolas; Seigneuric, Renaud; Fumoleau, Pierre; Garrido, Carmen; Gobbo, Jessica Journal: Cell adhesion & migration Issue: Volume 11:Issue 2(2017) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. (2nd January 2017) Authors: Rusakiewicz, Sylvie; Perier, Aurélie; Semeraro, Michaela; Pitt, Jonathan M.; Pogge von Strandmann, Elke; Reiners, Katrin S.; Aspeslagh, Sandrine; Pipéroglou, Christelle; Vély, Frédéric; Ivagnes, Alexandre; Jegou, Sarah; Halama, Niels; Chaigneau, Loic; Validire, Pierre; Christidis, Christos; Perni... Journal: Oncoimmunology Issue: Volume 6:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. (November 2017) Authors: Guerin, Mathilde; Rezai, Keyvan; Isambert, Nicolas; Campone, Mario; Autret, Aurélie; Pakradouni, Jihane; Provansal, Magali; Camerlo, Jacques; Sabatier, Renaud; Bertucci, François; Charafe-Jauffret, Emmanuelle; Hervieu, Alice; Extra, Jean-Marc; Viens, Patrice; Lokiec, François; Boher, Jean-Marie; ... Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group. (September 2017) Authors: Penel, Nicolas; Le Cesne, Axel; Bonvalot, Sylvie; Giraud, Antoine; Bompas, Emmanuelle; Rios, Maria; Salas, Sébastien; Isambert, Nicolas; Boudou-Rouquette, Pascaline; Honore, Charles; Italiano, Antoine; Ray-Coquard, Isabelle; Piperno-Neumann, Sophie; Gouin, François; Bertucci, François; Ryckewaert... Journal: European journal of cancer Issue: Volume 83(2017) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗